The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Dendritic Cell Vaccine Market Research Report 2025

Global Dendritic Cell Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1801530

No of Pages : 107

Synopsis
Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option.
Global Dendritic Cell Vaccine market is projected to reach US$ 80 million in 2029, increasing from US$ 63 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dendritic Cell Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dendritic Cell Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon Corporation)
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck & Co.
Segment by Type
Non-Targeted
Target
Segment by Application
Covid-19
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dendritic Cell Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Dendritic Cell Vaccine Market Overview
1.1 Product Overview and Scope of Dendritic Cell Vaccine
1.2 Dendritic Cell Vaccine Segment by Type
1.2.1 Global Dendritic Cell Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Non-Targeted
1.2.3 Target
1.3 Dendritic Cell Vaccine Segment by Application
1.3.1 Global Dendritic Cell Vaccine Market Value by Application: (2023-2029)
1.3.2 Covid-19
1.3.3 Cancer
1.3.4 Others
1.4 Global Dendritic Cell Vaccine Market Size Estimates and Forecasts
1.4.1 Global Dendritic Cell Vaccine Revenue 2018-2029
1.4.2 Global Dendritic Cell Vaccine Sales 2018-2029
1.4.3 Global Dendritic Cell Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dendritic Cell Vaccine Market Competition by Manufacturers
2.1 Global Dendritic Cell Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dendritic Cell Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dendritic Cell Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Dendritic Cell Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Dendritic Cell Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dendritic Cell Vaccine, Product Type & Application
2.7 Dendritic Cell Vaccine Market Competitive Situation and Trends
2.7.1 Dendritic Cell Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dendritic Cell Vaccine Players Market Share by Revenue
2.7.3 Global Dendritic Cell Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dendritic Cell Vaccine Retrospective Market Scenario by Region
3.1 Global Dendritic Cell Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dendritic Cell Vaccine Global Dendritic Cell Vaccine Sales by Region: 2018-2029
3.2.1 Global Dendritic Cell Vaccine Sales by Region: 2018-2023
3.2.2 Global Dendritic Cell Vaccine Sales by Region: 2024-2029
3.3 Global Dendritic Cell Vaccine Global Dendritic Cell Vaccine Revenue by Region: 2018-2029
3.3.1 Global Dendritic Cell Vaccine Revenue by Region: 2018-2023
3.3.2 Global Dendritic Cell Vaccine Revenue by Region: 2024-2029
3.4 North America Dendritic Cell Vaccine Market Facts & Figures by Country
3.4.1 North America Dendritic Cell Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dendritic Cell Vaccine Sales by Country (2018-2029)
3.4.3 North America Dendritic Cell Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dendritic Cell Vaccine Market Facts & Figures by Country
3.5.1 Europe Dendritic Cell Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dendritic Cell Vaccine Sales by Country (2018-2029)
3.5.3 Europe Dendritic Cell Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dendritic Cell Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Dendritic Cell Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dendritic Cell Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Dendritic Cell Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dendritic Cell Vaccine Market Facts & Figures by Country
3.7.1 Latin America Dendritic Cell Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dendritic Cell Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Dendritic Cell Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dendritic Cell Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Dendritic Cell Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dendritic Cell Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dendritic Cell Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dendritic Cell Vaccine Sales by Type (2018-2029)
4.1.1 Global Dendritic Cell Vaccine Sales by Type (2018-2023)
4.1.2 Global Dendritic Cell Vaccine Sales by Type (2024-2029)
4.1.3 Global Dendritic Cell Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Dendritic Cell Vaccine Revenue by Type (2018-2029)
4.2.1 Global Dendritic Cell Vaccine Revenue by Type (2018-2023)
4.2.2 Global Dendritic Cell Vaccine Revenue by Type (2024-2029)
4.2.3 Global Dendritic Cell Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Dendritic Cell Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dendritic Cell Vaccine Sales by Application (2018-2029)
5.1.1 Global Dendritic Cell Vaccine Sales by Application (2018-2023)
5.1.2 Global Dendritic Cell Vaccine Sales by Application (2024-2029)
5.1.3 Global Dendritic Cell Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Dendritic Cell Vaccine Revenue by Application (2018-2029)
5.2.1 Global Dendritic Cell Vaccine Revenue by Application (2018-2023)
5.2.2 Global Dendritic Cell Vaccine Revenue by Application (2024-2029)
5.2.3 Global Dendritic Cell Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Dendritic Cell Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 3M Dendritic Cell Vaccine Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Activarti
6.2.1 Activarti Corporation Information
6.2.2 Activarti Description and Business Overview
6.2.3 Activarti Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Activarti Dendritic Cell Vaccine Product Portfolio
6.2.5 Activarti Recent Developments/Updates
6.3 Argos Therapeutics
6.3.1 Argos Therapeutics Corporation Information
6.3.2 Argos Therapeutics Description and Business Overview
6.3.3 Argos Therapeutics Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Argos Therapeutics Dendritic Cell Vaccine Product Portfolio
6.3.5 Argos Therapeutics Recent Developments/Updates
6.4 Batavia Bioservices
6.4.1 Batavia Bioservices Corporation Information
6.4.2 Batavia Bioservices Description and Business Overview
6.4.3 Batavia Bioservices Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Batavia Bioservices Dendritic Cell Vaccine Product Portfolio
6.4.5 Batavia Bioservices Recent Developments/Updates
6.5 Bellicum Pharmaceuticals
6.5.1 Bellicum Pharmaceuticals Corporation Information
6.5.2 Bellicum Pharmaceuticals Description and Business Overview
6.5.3 Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bellicum Pharmaceuticals Dendritic Cell Vaccine Product Portfolio
6.5.5 Bellicum Pharmaceuticals Recent Developments/Updates
6.6 Creagene
6.6.1 Creagene Corporation Information
6.6.2 Creagene Description and Business Overview
6.6.3 Creagene Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Creagene Dendritic Cell Vaccine Product Portfolio
6.6.5 Creagene Recent Developments/Updates
6.7 DanDrit Biotech
6.6.1 DanDrit Biotech Corporation Information
6.6.2 DanDrit Biotech Description and Business Overview
6.6.3 DanDrit Biotech Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 DanDrit Biotech Dendritic Cell Vaccine Product Portfolio
6.7.5 DanDrit Biotech Recent Developments/Updates
6.8 DCPrime
6.8.1 DCPrime Corporation Information
6.8.2 DCPrime Description and Business Overview
6.8.3 DCPrime Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 DCPrime Dendritic Cell Vaccine Product Portfolio
6.8.5 DCPrime Recent Developments/Updates
6.9 Sanpower Corporation (Dendreon Corporation)
6.9.1 Sanpower Corporation (Dendreon Corporation) Corporation Information
6.9.2 Sanpower Corporation (Dendreon Corporation) Description and Business Overview
6.9.3 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product Portfolio
6.9.5 Sanpower Corporation (Dendreon Corporation) Recent Developments/Updates
6.10 Elios Therapeutics
6.10.1 Elios Therapeutics Corporation Information
6.10.2 Elios Therapeutics Description and Business Overview
6.10.3 Elios Therapeutics Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Elios Therapeutics Dendritic Cell Vaccine Product Portfolio
6.10.5 Elios Therapeutics Recent Developments/Updates
6.11 ImmunoCellular Therapeutics
6.11.1 ImmunoCellular Therapeutics Corporation Information
6.11.2 ImmunoCellular Therapeutics Dendritic Cell Vaccine Description and Business Overview
6.11.3 ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ImmunoCellular Therapeutics Dendritic Cell Vaccine Product Portfolio
6.11.5 ImmunoCellular Therapeutics Recent Developments/Updates
6.12 Immunicum
6.12.1 Immunicum Corporation Information
6.12.2 Immunicum Dendritic Cell Vaccine Description and Business Overview
6.12.3 Immunicum Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Immunicum Dendritic Cell Vaccine Product Portfolio
6.12.5 Immunicum Recent Developments/Updates
6.13 Kiromic
6.13.1 Kiromic Corporation Information
6.13.2 Kiromic Dendritic Cell Vaccine Description and Business Overview
6.13.3 Kiromic Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Kiromic Dendritic Cell Vaccine Product Portfolio
6.13.5 Kiromic Recent Developments/Updates
6.14 Medigene
6.14.1 Medigene Corporation Information
6.14.2 Medigene Dendritic Cell Vaccine Description and Business Overview
6.14.3 Medigene Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Medigene Dendritic Cell Vaccine Product Portfolio
6.14.5 Medigene Recent Developments/Updates
6.15 Merck & Co.
6.15.1 Merck & Co. Corporation Information
6.15.2 Merck & Co. Dendritic Cell Vaccine Description and Business Overview
6.15.3 Merck & Co. Dendritic Cell Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Merck & Co. Dendritic Cell Vaccine Product Portfolio
6.15.5 Merck & Co. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dendritic Cell Vaccine Industry Chain Analysis
7.2 Dendritic Cell Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dendritic Cell Vaccine Production Mode & Process
7.4 Dendritic Cell Vaccine Sales and Marketing
7.4.1 Dendritic Cell Vaccine Sales Channels
7.4.2 Dendritic Cell Vaccine Distributors
7.5 Dendritic Cell Vaccine Customers
8 Dendritic Cell Vaccine Market Dynamics
8.1 Dendritic Cell Vaccine Industry Trends
8.2 Dendritic Cell Vaccine Market Drivers
8.3 Dendritic Cell Vaccine Market Challenges
8.4 Dendritic Cell Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’